In one of the breast cancertypes, human epidermal growth factor receptor 2 (HER2) is overexpressedin 20% of cases.3,4 The survival time of HER2-positivebreast cancer patients is significantly shorter due to the aggressiveform of the disease. This evidence concerns the gene ERBB2 and cancer.